-
11月30日2022In China for Global|Teddylab participated in the "OCT DAH 2022" 2022 German Clinical Trial Outsourcing Conference
On November 30, 2022, Teddylab was invited to participate in the "OCT DAH 2022" 2022 German Clinical Trial Outsourcing Conference, introducing to European industry peers that Teddylab is a leading enterprise in China's CRO central laboratory, providing professional biomedical and medical device clinical research laboratory services, including providing central laboratory testing and central pathology services, related project management, logistics management, and data management as one-stop services. At the exhibition, as the leading central laboratory in China among the participating institutions, Teddylab attracted many European pharmaceutical companies interested in the Chinese market to consult on policies and regulations related to clinical trials in China. At the same time, Teddylab also used this opportunity to participate in the OCT DAH International Exhibition to help Chinese companies find excellent overseas laboratory partners in Europe, providing global one-stop central laboratory services for domestic and foreign customers
-
11月18日2022观合医药受邀出席无锡国家高新区高质量发展大会
时代风起,太湖潮涌。1992年,沐浴着改革开放的春风,无锡高新区应运而生。30年锐意改革、开拓进取,无锡高新区不仅成为无锡重要的经济增长支柱和科技创新高地,更在全国高新区建设发展史上留下浓墨重彩的一笔。观合医药作为2020年无锡高新区首批引进和重点支持的一家生物医药平台型CRO创新企业,受邀出席由无锡政府主办的无锡国家高新区高质量发展大会。
-
03月30日2019观合医药血液病诊疗专题论坛成功在杭举办
2019年3月30日,第五届中美病理高峰论坛-观合医药血液病诊疗专题论坛于杭州成功举办。论坛邀请了来自美国约翰·霍普金斯大学医学院、美国内布拉斯加大学医学中心、北京陆道培医院、华中科技大学同济医学院附属同济医院、迪安诊断以及观合医药的7位知名专家,从血液病最新诊疗进展与检测技术出发,共同探讨如何更好地推动全球血液病的药物研发与转化、临床诊断与治疗。